Exostar partners with SIGNiX

To deliver secure, compliant digital signature solution to life science and healthcare

Exostar, an innovative information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, and SIGNiX, provider of Independent E-Signatures, announced a partnership that brings SIGNiX’s digital signature solution to Exostar’s life science and healthcare communities. With SIGNiX becoming Exostar’s latest Application Partner, organisations and individuals connected to Exostar’s Life Sciences Identity Hub can leverage secure, single sign-on access to SIGNiX to quickly and easily sign business-critical and sensitive documents and forms online.

SIGNiX’s Independent E-Signatures comply with global life sciences and healthcare industry standards and regulations, including the FDA’s 21 CFR Part 11, HIPAA, and the ESIGN Act. They have also been approved by the SAFE-BioPharma Association, the non-profit organisation that manages digital identity and signature standards for the pharmaceutical, biotech, and healthcare industries.

Researchers, investigators, patients, providers, and clinical trial participants benefit from signature process enforcement, faster document turnaround, reduced operating costs, and the flexibility to sign, send, and track documents from any device with an Internet connection.

Users determine where documents reside, including on their own servers, rather than the vendor’s external server. Legal evidence is permanently embedded into the signed document so that signatures can be verified offline, anytime. Since the legal evidence behind each signature is permanently embedded into the signed document and signatures adhere to international, published standards, they are valid virtually forever, as long as a digital copy of the signed document exists. Users get immediate and complete access to the evidence of the signature’s validity through a comprehensive audit trail.

Exostar’s cloud-based Life Sciences Identity Hub supports a community of nearly 1,000 organisations and 20,000 individuals worldwide in their life science and healthcare endeavours. It serves not only as a platform that enables secure, internal and external collaboration, but also as a single sign-on entry point to a wealth of connected applications and solution provider portals that advance business objectives. Owners of connected assets define permission and user authentication strategies and rules, which are enforced by Exostar’s Secure Access Manager. Coupled with extensive platform security and audit capabilities, application providers receive a secure connection experience, while sponsor organisations are assured their sensitive information and intellectual property are protected from compromise.